3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
1
Neoplasm Metastasis
1
Lung Neoplasms
1
Interventions
Gemcitabine
74
Paclitaxel
60
Capecitabine
60
Fluorouracil
58
Oxaliplatin
57
Docetaxel
51
Bevacizumab
51
Leucovorin
48
Nivolumab
41
Irinotecan
40
Cisplatin
40
Carboplatin
37
Cetuximab
34
Radiosurgery
33
pembrolizumab
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Albumin-Bound Paclitaxel
21
Pemetrexed
20
Doxorubicin
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
SR 48692
×
Clear all
NCT00290953
2008-12-23
SESAME
Sanofi
Phase 2/3
Completed
432 enrolled